Evidence map›Paper›PMID 35323693›Full record

ArticleMetabolites2022

FOXO3 Expression in Macrophages Is Lowered by a High-Fat Diet and Regulates Colonic Inflammation and Tumorigenesis.

Rida Iftikhar, Harrison M Penrose, Angelle N King, Yunah Kim, Emmanuelle Ruiz, Emad Kandil, Heather L Machado, Suzana D Savkovic

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. FOXO3: at the crossroads of metabolic, inflammatory, and tumorigenic remodeling in the colon.American journal of physiology. Gastrointestinal and liver physiology · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Rida IftikharDepartment of Pathology and Laboratory Medicine, School of Medicine, Tulane University, New Orleans, LA 70012, USA.
Harrison M PenroseDepartment of Pathology and Laboratory Medicine, School of Medicine, Tulane University, New Orleans, LA 70012, USA.
Angelle N KingDepartment of Pathology and Laboratory Medicine, School of Medicine, Tulane University, New Orleans, LA 70012, USA.
Yunah KimDepartment of Pathology and Laboratory Medicine, School of Medicine, Tulane University, New Orleans, LA 70012, USA.
Emmanuelle RuizDivision of Endocrine and Oncologic Surgery, Department of Surgery, Tulane University, New Orleans, LA 70012, USA.
Emad KandilDivision of Endocrine and Oncologic Surgery, Department of Surgery, Tulane University, New Orleans, LA 70012, USA.
Heather L MachadoDepartment of Biochemistry and Molecular Biology, School of Medicine, Tulane University, New Orleans, LA 70012, USA.ORCID 0000-0001-6889-6139
Suzana D SavkovicDepartment of Pathology and Laboratory Medicine, School of Medicine, Tulane University, New Orleans, LA 70012, USA.
Tulane University · US

Funding

Epstein Barr virus antisense transcriptionR01AI106676 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2014 to 2018
$1.9M
Mechanisms promoting the transition to invasive cancerR01CA212518 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI MACHADO, HEATHER L · 2017 to 2021
$1.8M
RPMS1 circular RNAs in EBV malignanciesR01CA243793 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2019 to 2023
$1.8M
Regulation of DGAT - dependent lipogenesis in colonic epithelial growthR01CA252055 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI SAVKOVIC, SUZANA D. · 2021 to 2025
$1.6M
NCI NIH HHS R01 CA212518NCI NIH HHS R01 CA243793NCI NIH HHS R01 CA252055NIAID NIH HHS R01 AI106676NIH HHS CA212518NIH HHS CA252055
6 · The paper itself

Abstract

Obesity, characterized by augmented inflammation and tumorigenesis, is linked to genetic predispositions, such as FOXO3 polymorphisms. As obesity is associated with aberrant macrophages infiltrating different tissues, including the colon, we aimed to identify FOXO3-dependent transcriptomic changes in macrophages that drive obesity-mediated colonic inflammation and tumorigenesis. We found that in mouse colon, high-fat-diet-(HFD)-related obesity led to diminished FOXO3 levels and increased macrophages. Transcriptomic analysis of mouse peritoneal FOXO3-deficient macrophages showed significant differentially expressed genes (DEGs; FDR < 0.05) similar to HFD obese colons. These DEG-related pathways, linked to mouse colonic inflammation and tumorigenesis, were similar to those in inflammatory bowel disease (IBD) and human colon cancer. Additionally, we identified a specific transcriptional signature for the macrophage-FOXO3 axis (MAC-FOXO382), which separated the transcriptome of affected tissue from control in both IBD (p = 5.2 × 10−8 and colon cancer (p = 1.9 × 10−11), revealing its significance in human colonic pathobiologies. Further, we identified (heatmap) and validated (qPCR) DEGs specific to FOXO3-deficient macrophages with established roles both in IBD and colon cancer (IL-1B, CXCR2, S100A8, S100A9, and TREM1) and those with unexamined roles in these colonic pathobiologies (STRA6, SERPINH1, LAMB1, NFE2L3, OLR1, DNAJC28 and VSIG10). These findings establish an important understanding of how HFD obesity and related metabolites promote colonic pathobiologies.

Indexed as

colon cancerFOXO3IBDinflammationmacrophagesobesitytumorigenesis

Identifiers

PMID35323693
PMCPMC8949544
OpenAlexW4220901020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.